Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 39

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 39
---
, LLC and, as such, disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. |

| (9) | Consists of 143,912 stock options exercisable within 60 days of March 20, 2025. |

| (10) | Consists of 101,040 stock options exercisable within 60 days of March 20, 2025. |

| (11) | Consists of 59,261 stock options exercisable within 60 days of March 20, 2025. |

| (12) | Consists of 59,261 stock options exercisable within 60 days of March 20, 2025. |

| (13) | As reported in a statement on Schedule 13D/A filed with the SEC on August 5, 2024 by AI Day1 LLC (“AI Day1”) and its affiliates and a Form 4 filed on August 5, 2024. Represents (i) 12,929,322 shares held by AI Day1 and (ii) 827,586 shares issuable upon exercise of certain warrants to purchase common stock held by AI Day1 that are exercisable within 60 days of March 20, 2025 and may be deemed to be beneficially owned by Access Industries Holdings LLC (“AIH”), Access Industries Management, LLC (“AIM”) and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. The business address and principal executive offices of each of AI Day1, AIH, AIM and Mr. Blavatnik is c/o Access Industries, Inc., 40 West 57thStreet, 28thFl., New York, NY 10019. |

| (14) | As reported in a statement on Schedule 13G/A filed with the SEC on February 12, 2025 by FMR LLC and its affiliates, and represents 12,887,467 shares of our common stock beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies. The business address and principal executive offices of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210. |

| (15) | As reported in a statement on Schedule 13G/A